Sign inJoin waitlistJoin the waitlist

Marc Matrana

Director, Precision Cancer Therapies Program · Ochsner Clinic Foundation

Credentials: · · · · · · ·

History

Precision Cancer Therapies Program · Ochsner Clinic Foundation
Present

Medical Oncology
2009–2011
Internal Medicine
Ochsner Clinic Foundation
2006–2009
Tulane University
Louisiana State Univ Sch of Med in New Orleans
2002–2006
Tulane University
1998–2002

Research

A Phase II Basket Trial of Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare Tumors (DART SWOG 1609) in Patients with Nonpancreatic Neuroendocrine Tumors
Clinical Cancer Research · 2020 · 269 citations
The impact of gender on The efficacy of immune checkpoint inhibitors in cancer patients: The MOUSEION-01 study
Critical Reviews in Oncology/Hematology · 2022 · 146 citations
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials
Review · Nature Reviews Clinical Oncology · 2021 · 108 citations

Francesco Massari
27 papers · 6 as a fellow
Nizar Tannir
13 papers
Zin Myint
11 papers
Diana Maslov
6 papers · 6 as a resident
Eric Jonasch
6 papers
Liang Cheng
6 papers
AS
Aditya Shetty
5 papers · 5 as a fellow
Karine Tawagi
5 papers · 5 as a fellow
Paul Corn
4 papers
Sravanti Teegavarapu
4 papers
Adedayo Onitilo
3 papers
BP
Benjamin Parsons
3 papers

Clinical trials

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Site PI · Recruiting · Phase 3
National Cancer Institute (NCI)
2020–2027
Prebiotics in Rectal Cancer
Sub-investigator · Unknown
Ochsner Health System
2022–2024